Onconomics Plus

What can be evaluated with the Onconomics Plus Profile:

  • Panel of 72 Tumor-Related Genes by Gene Expression Profile Evaluated by cDNA Micro-Arrays.
  • PD-1 / PD-L1 markers
  • Chemistry of Efficacy and Resistance of Cytotoxic Drugs
  • Chemistry of Extracts and Natural Substances with Cellular Apoptosis Induction
  • Epigenetic Profile for DNA Methylation with Guidance for Target Therapies
  • Resistance Factor Markers
  • Circulating Tumor Cells (CTC’s) and Cancer Stem Cells (CSC’S)
  • Sensitivity to Heat Shock Proteins (HSP) for Radiotherapies and Hyperthermia.